Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT02254824
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT02254824
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02254824. Randomized; no masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2015-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients
- Condition
- Hypertension
- Intervention (Drug)
- Xuezhikang
- Intervention (Drug)
- Atorvastatin
- Intervention (Behavioral)
- Lifestyle modification
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator
- Peking University First Hospital
- Collaborator
- Peking Union Medical College Hospital
- Collaborator
- Beijing Hospital of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct02254824- Content hash
b737424aa705169439151851073988bd18e72d0b8270b8daabdfa6b615655efc